<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131289">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02128477</url>
  </required_header>
  <id_info>
    <org_study_id>BIO012014</org_study_id>
    <nct_id>NCT02128477</nct_id>
  </id_info>
  <brief_title>Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients</brief_title>
  <acronym>PRD-MI</acronym>
  <official_title>Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients: Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thebiosignals.com</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thebiosignals.com</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased periodic repolarization dynamics (PRD) indicate increased risk of death in cardiac
      patients. This study thoughts to prospectively validate the prognostic value of PRD in
      post-infarction patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodic repolarization dynamics (PRD) reflect periodic changes of repolarization
      instability located in the low-frequency spectral range. Level of PRD can be assessed using
      a high resolution surface ECG recorded in the 12-leads of Frank leads configuration during
      resting conditions.

      Increased levels of PRD have been associated with sympathetic overactivity and increased
      risk of mortality in survivors of acute myocardial infarction and patients undergoing a
      clinically indicated exercise test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of total deaths</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of cardiovascular deaths</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        myocardial infarction
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previous myocardial infarction &gt;4 weeks

          -  age &gt;18 years

        Exclusion Criteria:

          -  life expectancy &lt; 1 year due to non-cardiac causes

          -  unable to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Axel Bauer, MD</last_name>
    <phone>+49 7071 29 82922</phone>
    <email>bauer.de@googlemail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Zuern, MD</last_name>
    <phone>+49 7071 29 83153</phone>
    <email>christine.zuern@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eberhard-Karls-University Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 29, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Repolarization instability</keyword>
  <keyword>Ventricular fibrillation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
